Nephrology & urology
Kidney & urinary clinical trials
Kidney disease and conditions of the bladder and urinary tract. We’re tracking 4,387 recruiting studies in this area right now.
By phase
- Not applicable2,710
- Phase 2569
- Phase 1367
- Phase 3266
- Phase 1/Phase 2227
- Phase 4192
- Phase 2/Phase 356
Top conditions
- Prostate Cancer645
- Bladder Cancer186
- Acute Kidney Injury133
- Chronic Kidney Diseases123
- Chronic Kidney Disease107
- Breast Cancer105
- Renal Cell Carcinoma80
- Urinary Incontinence60
- Kidney Cancer59
- Colorectal Cancer58
- Ovarian Cancer57
- Lung Cancer51
- Cancer48
- Lupus Nephritis48
- Melanoma48
- Metastatic Prostate Cancer47
- Head and Neck Cancer46
- Prostate Cancer (Adenocarcinoma)45
Leading sponsors
- Mayo Clinic64
- National Cancer Institute (NCI)48
- Peking University First Hospital39
- M.D. Anderson Cancer Center36
- Novartis Pharmaceuticals34
- Chinese University of Hong Kong33
- AstraZeneca29
- IRCCS Azienda Ospedaliero-Universitaria di Bologna29
- Memorial Sloan Kettering Cancer Center29
- Assistance Publique - Hôpitaux de Paris27
Where studies are running
- California359
- Arizona109
- Alabama107
- Florida95
- New York95
- Maryland91
- Texas91
- Massachusetts89
- Illinois66
- Minnesota50
Recruiting studies4,387 total
- NCT07745920Recruiting
An online program for depression in people with adpkd
This study tests an internet-based program to help manage depression symptoms in people with ADPKD. The program may be a convenient way to get support for your mood without traveling to a clinic.
Rochester, MinnesotaAges 18–70 - NCT07748858Recruiting
Heart care support for older African American patients
This study aims to improve care for older African American patients with heart conditions and other health problems. It tests ways to provide more patient-centered support.
Birmingham, AlabamaAges 50–99 - NCT07746297Recruiting
Sexual health survey for Spanish-speaking adults
This study is a short online survey about sexual health in Spanish-speaking adults. Your answers may help researchers better understand sexual well-being in this community.
Santander, CantabriaAges 18 years+ - NCT07747272Recruiting
Nerve-sparing prostate surgery and erectile function
This study looks at how your health before surgery affects your erectile function after robot-assisted prostate removal. It aims to help doctors predict and improve recovery of erectile function.
Florence, ItalyAges 18–75 - NCT07742358Recruiting
Comparing ureteral stent designs in children with kidney stones
This trial compares two types of ureteral stents (small tubes that help urine drain from the kidney to the bladder) in children having surgery for kidney stones. The goal is to see which type causes fewer symptoms like pain or discomfort.
Toronto, OntarioAges 8–18 - NCT07744932RecruitingPhase 2
Radiation plus drug combo for kidney cancer that has spread a little
This trial tests a combination of targeted radiation, an oral drug (axitinib), and an immunotherapy (toripalimab) for people with kidney cancer that has spread to a few spots. It aims to see if this combo helps control the cancer longer.
Shijiazhuang, HebeiAges 18 years+ - NCT07741448RecruitingPhase 2
Chemo and targeted drug before surgery for HER2-positive upper tract cancer
This trial tests a combination of chemotherapy (gemcitabine) and a targeted drug (Trastuzumab Rezetecan) before surgery to remove the kidney and ureter. It may help shrink the tumor and improve outcomes for people with HER2-positive upper tract urothelial cancer.
Huanggang, HubeiAges 18–75 - NCT07741929Recruiting
Genetic testing experiences for prostate cancer
This study looks at how patients and doctors feel about genetic testing for prostate cancer. It aims to improve how genetic risk information is shared and understood.
LondonAges 18–100 - NCT07743749Recruiting
MRI-based study to classify and grade kidney tumors
This study uses MRI scans to help doctors better identify the type and severity of kidney tumors. It may lead to more accurate diagnoses without needing extra tests.
BeijingAges 18 years+ - NCT07748988RecruitingPhase 1
Casdatifan for advanced kidney cancer that has stopped responding
This study tests a new pill called casdatifan for people with advanced kidney cancer that has not improved after standard treatments. The goal is to see if the drug can shrink tumors and be safe to take.
Nashville, TennesseeAges 18–100 - NCT02979951Recruiting
IV fosfomycin for serious bacterial infections
This trial studies whether IV (through a vein) fosfomycin can treat severe bacterial infections in adults. It may help people whose infection is covered by the standard fosfomycin use and who need hospital-level care.
Hall in TirolAges 18 years+ - NCT06613269RecruitingPhase 2
PET-guided radiation therapy for clear cell kidney cancer
This trial tests whether a special PET/CT scan (68Ga-NY104) can help guide radiation therapy for people with clear cell kidney cancer. The goal is to make radiation more precise and effective for treating tumors that haven't spread too much.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06622915Recruiting
Heart health in kids with kidney condition
This study looks at how different types of nephrotic syndrome affect heart function in children. It may help doctors understand the heart risks in kids who need steroids for a long time compared to those whose condition doesn't respond to steroids.
SohagAges 2–14 - NCT07733583Recruiting
Pelvic floor therapy and exercise for endometriosis pain
This study tests whether a special type of physical therapy (pelvic floor therapy) combined with exercise can help reduce chronic pelvic pain in women with endometriosis. It aims to see if these treatments improve pain, daily function, and quality of life.
Porto Alegre, Rio Grande do SulAges 18–45 - NCT07739121Recruiting
Testing AI vs. tumor boards for cancer treatment advice
This trial compares treatment recommendations from large language models (AI) against those from experienced tumor boards for five common cancer types. The goal is to see if AI can help doctors make better decisions.
Boulogne-BillancourtAges 18 years+ - NCT07740239Recruiting
Study on frailty in seriously ill adults
This study looks at why some seriously ill adults become frail. It involves imaging and other tests to help doctors better understand and care for patients with serious conditions.
TampereAges Any age - NCT07734207Recruiting
Nocturia app and behavior help trial
This trial tests if a smartphone app (LINE) and simple behavior changes can reduce how often you wake up to urinate at night. You may qualify if you get up to pee at least twice each night.
DouliuAges 55 years+ - NCT07737561Recruiting
Exercise test for heart, kidney, and metabolic health
This study looks at how blood pressure and artery stiffness respond to exercise in people with heart, kidney, and metabolic problems. It may help doctors better understand your condition.
KaramanAges 18 years+ - NCT07734636RecruitingPhase 4
Restarting blood pressure meds after kidney injury
This study tests whether safely restarting a common blood pressure or kidney medicine (an ACE inhibitor or ARB) after a kidney injury can help protect your kidneys and heart. It might be a good option if your kidney function is improving and you aren't on dialysis.
San Francisco, CaliforniaAges 18 years+ - NCT07733167RecruitingPhase 3
Epinephrine injection during prostate surgery for large prostates
This study tests whether injecting a drug called epinephrine into the prostate during surgery can improve outcomes for men with large prostates. It aims to reduce bleeding and make the surgery safer and more effective.
Banhā, Qalyubia GovernorateAges 40 years+ - NCT07740629Recruiting
Video to reduce anxiety before urodynamics test
This trial tests if watching an educational video before a urodynamics test (a bladder function test) can help lower anxiety. It is for women who have never had this test before.
Kfar Saba, IsraelAges 18 years+ - NCT07735377RecruitingPhase 1
Study of SHR-6914 for Prostate Cancer
This study tests a new drug called SHR-6914 in men with prostate cancer that has spread. The goal is to see if it is safe and helps shrink or control the cancer, and to learn how the body processes it.
Guangzhou, GuangdongAges 18–80 - NCT07734610RecruitingPhase 1
Testing Nemtabrutinib in People with Severe Kidney Disease
This trial tests a new medicine (nemtabrutinib) in people with severe kidney disease to see how the body handles it. The study helps doctors decide safe doses for people with kidney problems.
Miami Lakes, FloridaAges 18–80 - NCT05679024RecruitingPhase 3
Apixaban to prevent stroke in atrial fibrillation and kidney failure
This trial tests apixaban (a blood thinner) to prevent stroke in people with atrial fibrillation or atrial flutter who have very poor kidney function or are on dialysis. If you qualify, you may help researchers find a safer way to lower stroke risk for this higher-risk group.
HelsinkiAges 18 years+
Common questions
- How many kidney & urinary clinical trials are recruiting?
- Clin2 is tracking 4,387 recruiting nephrology & urology studies from the U.S. registry right now, out of 6,805 we cover in this area in total.
- What does “Kidney & urinary” cover here?
- Kidney disease and conditions of the bladder and urinary tract. We group each study into kidney & urinary based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a kidney & urinary trial near me?
- Use the search to filter kidney & urinary studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.